Kyoto, Japan

Ken Inose

This inventor holds 3 USPTO granted patents. Top assignee: Arkray, Inc.. Active years: 2007-2009.


Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ken Inose: Innovator in DNA Detection Technologies

Introduction

Ken Inose is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of DNA detection and amplification technologies. With a total of 3 patents to his name, Inose continues to push the boundaries of innovation in molecular biology.

Latest Patents

Inose's latest patents include a method for detecting DNA through PCR, which utilizes DNA obtained from a sample as a template. This method is designed to amplify specific nucleotide sequences, enhancing sensitivity and specificity in detection. Another notable patent is a DNA amplification method and kit that employs a unique combination of sense and antisense primers, allowing for improved PCR efficiency. These advancements showcase his commitment to developing cutting-edge solutions in genetic research.

Career Highlights

Ken Inose is currently associated with Arkray, Inc., a company known for its innovative healthcare solutions. His work at Arkray has positioned him as a key player in the development of advanced diagnostic tools. Inose's expertise in molecular biology has been instrumental in driving the company's research initiatives forward.

Collaborations

Inose collaborates with talented individuals such as Satoshi Hashiguchi and Miki Horii. Their combined efforts contribute to the success of various projects within the company, fostering a collaborative environment that encourages innovation.

Conclusion

Ken Inose's contributions to DNA detection technologies exemplify his dedication to advancing scientific research. His innovative patents and collaborative spirit continue to inspire progress in the field of molecular biology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…